The evolution of the EGFRvIII (rindopepimut) immunotherapy for glioblastoma multiforme patients
Published 2015 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
The evolution of the EGFRvIII (rindopepimut) immunotherapy for glioblastoma multiforme patients
Authors
Keywords
-
Journal
Human Vaccines & Immunotherapeutics
Volume 10, Issue 11, Pages 3322-3331
Publisher
Informa UK Limited
Online
2015-01-28
DOI
10.4161/21645515.2014.983002
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Phase I/IIa trial of fractionated radiotherapy, temozolomide, and autologous formalin-fixed tumor vaccine for newly diagnosed glioblastoma
- (2014) Eiichi Ishikawa et al. JOURNAL OF NEUROSURGERY
- Odds of death after glioblastoma diagnosis in the United States by chemotherapeutic era
- (2014) Mitchell S. Wachtel et al. Cancer Medicine
- Intrathecal Humoral Immunity to Encephalitic RNA Viruses
- (2013) Timothy Phares et al. Viruses-Basel
- The Addition of Bevacizumab to Standard Radiation Therapy and Temozolomide Followed by Bevacizumab, Temozolomide, and Irinotecan for Newly Diagnosed Glioblastoma
- (2011) J. J. Vredenburgh et al. CLINICAL CANCER RESEARCH
- Improved survival time trends for glioblastoma using the SEER 17 population-based registries
- (2011) Matthew Koshy et al. JOURNAL OF NEURO-ONCOLOGY
- Annual Report to the Nation on the Status of Cancer, 1975-2007, Featuring Tumors of the Brain and Other Nervous System
- (2011) B. A. Kohler et al. JNCI-Journal of the National Cancer Institute
- Gene Expression Profile Correlates with T-Cell Infiltration and Relative Survival in Glioblastoma Patients Vaccinated with Dendritic Cell Immunotherapy
- (2010) Robert M. Prins et al. CLINICAL CANCER RESEARCH
- Glioma-Associated Cancer-Initiating Cells Induce Immunosuppression
- (2010) J. Wei et al. CLINICAL CANCER RESEARCH
- Dendritic cell vaccines to combat glioblastoma
- (2010) Christopher J Wheeler Expert Review of Neurotherapeutics
- Immunologic Escape After Prolonged Progression-Free Survival With Epidermal Growth Factor Receptor Variant III Peptide Vaccination in Patients With Newly Diagnosed Glioblastoma
- (2010) John H. Sampson et al. JOURNAL OF CLINICAL ONCOLOGY
- Phase I Study of Single-Agent Anti–Programmed Death-1 (MDX-1106) in Refractory Solid Tumors: Safety, Clinical Activity, Pharmacodynamics, and Immunologic Correlates
- (2010) Julie R. Brahmer et al. JOURNAL OF CLINICAL ONCOLOGY
- Phase I Trial of a Personalized Peptide Vaccine for Patients Positive for Human Leukocyte Antigen–A24 With Recurrent or Progressive Glioblastoma Multiforme
- (2010) Mizuhiko Terasaki et al. JOURNAL OF CLINICAL ONCOLOGY
- Phase II Study of Bevacizumab Plus Temozolomide During and After Radiation Therapy for Patients With Newly Diagnosed Glioblastoma Multiforme
- (2010) Albert Lai et al. JOURNAL OF CLINICAL ONCOLOGY
- Induction of CD8+ T-Cell Responses Against Novel Glioma–Associated Antigen Peptides and Clinical Activity by Vaccinations With α-Type 1 Polarized Dendritic Cells and Polyinosinic-Polycytidylic Acid Stabilized by Lysine and Carboxymethylcellulose in Patients With Recurrent Malignant Glioma
- (2010) Hideho Okada et al. JOURNAL OF CLINICAL ONCOLOGY
- Greater chemotherapy-induced lymphopenia enhances tumor-specific immune responses that eliminate EGFRvIII-expressing tumor cells in patients with glioblastoma
- (2010) J. H. Sampson et al. NEURO-ONCOLOGY
- Bevacizumab Alone and in Combination With Irinotecan in Recurrent Glioblastoma
- (2009) Henry S. Friedman et al. JOURNAL OF CLINICAL ONCOLOGY
- An epidermal growth factor receptor variant III-targeted vaccine is safe and immunogenic in patients with glioblastoma multiforme
- (2009) J. H. Sampson et al. MOLECULAR CANCER THERAPEUTICS
- Vaccination Elicits Correlated Immune and Clinical Responses in Glioblastoma Multiforme Patients
- (2008) C. J. Wheeler et al. CANCER RESEARCH
- Intercellular transfer of the oncogenic receptor EGFRvIII by microvesicles derived from tumour cells
- (2008) Khalid Al-Nedawi et al. NATURE CELL BIOLOGY
Publish scientific posters with Peeref
Peeref publishes scientific posters from all research disciplines. Our Diamond Open Access policy means free access to content and no publication fees for authors.
Learn MoreCreate your own webinar
Interested in hosting your own webinar? Check the schedule and propose your idea to the Peeref Content Team.
Create Now